A combination of homogeneous wall thickness and superior cosmetic quality is offered from Clareo vials from SGD Pharma, which for moulded glass Type II is distinctive in the market. The new range offers technical characteristics similar to the vials in the existing range and can replace them without any regulatory change. Once again, SGD Pharma demonstrates with Clareo its expertise in the control of manufacturing process of moulded glass.